Molsoft

San Diego, United States Founded: 1994 • Age: 32 yrs
Software solutions and services for computational chemistry are offered.

About Molsoft

Molsoft is a company based in San Diego (United States) founded in 1994. Molsoft offers products and services including ICM-Pro, ICM-Pro Homology Module, ICM-Pro Virtual Ligand Screening, ICM-Chemist, and MolScreen. Molsoft operates in a competitive market with competitors including Insitro, Certara, Helix, HotSpot Therapeutics and Benchling, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website molsoft.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Molsoft L.L.C.
Key Metrics
  • Latest Funding Round
    $399.25K (USD), Grant

    Apr 2010

  • Investors

Products & Services of Molsoft

Molsoft offers a comprehensive portfolio of products and services, including ICM-Pro, ICM-Pro Homology Module, ICM-Pro Virtual Ligand Screening, ICM-Chemist, and MolScreen.

ICM-Pro
Molecular Modeling Software

Desktop tool for molecular modeling and docking simulations.

ICM-Pro Homology Module
Bioinformatics Tool

Module for homology searches and structure-based alignments.

ICM-Pro Virtual Ligand Screening
Drug Discovery Software

Platform for high-throughput virtual screening of ligands.

ICM-Chemist
Cheminformatics Suite

Software for chemical drawing, database management, and enumeration.

MolScreen
AI Modeling Tool

Set of models for pharmacology and toxicology target prediction.

Apps and channels of Molsoft

its YouTube channel MolSoft Molecules in Silico has 3.86K subscribers and 30 videos.

MolSoft Molecules in Silico
YouTube 3.86K subscribers 30 videos Science & Technology
Open channel

Videos from Molsoft

The most watched videos on Molsoft's YouTube channel, MolSoft Molecules in Silico (3.86K subscribers). Click a video to play it here.

Adding Residues to a Protein Structure - Filling in the Gaps
2.4K views
How to Save a Docked Receptor Ligand Complex as PDB via the GUI and command line.
2.3K views
Peptide Docking in MolSoft's ICM-Pro
1.6K views
Ligand Docking in ICM: Small Molecules, Fragments, Covalent and Template-Based Methods
1.5K views

More on MolSoft Molecules in Silico.

Funding Insights of Molsoft

  • Total Rounds 6
  • Last Round Grant β€” $399,247
  • First Round $100,000

    (Feb 2009)

  • Investors Count 1

All 6 funding rounds of Molsoft with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2010$399,247Grant––
Mar 2010$399,247Grant––
Jul 2009$497,470Grant––
Jul 2009$497,470Grant––
Feb 2009$100,000Grant––
Feb 2009$100,000Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Molsoft

Molsoft has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Molsoft

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Molsoft

2 people are tracked at Molsoft (1 in leadership, 1 in team).

NameRoleGroup
Ruben Abagyan
FounderLeadership
Andrew Orry
Senior ScientistTeam
Premium access

Complete people profiles for Molsoft

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Molsoft

3 dated milestones of Molsoft across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Molsoft is founded.
  2. Funding First funding round of $100K.
  3. Funding Latest funding round, Grant, of $399K.

Competitors of Molsoft

Molsoft operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, Certara, Helix, HotSpot Therapeutics and Benchling, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
insitro.com2018San Francisco, United States$643.21M257
An AI-enabled platform is developed for infectious disease treatment.
certara.com2008Princeton, United States–827
Provider of a platform for in silico drug discovery and consulting services
helix.com2015San Francisco, United States$435M–
Genomic database for clinical research is provided.
hotspotthera.com2017Boston, United States$210M37
Developer of a platform for protein function analysis
benchling.com2012San Francisco, United States$411.9M640
Cloud-based bioinformatics platform is offered for biotech research.
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
ingenuity.com1998Redwood, United States$20.4M30
Genomic data is analyzed and interpreted via web-based applications.
genuitysci.com2013Boston, United States$515M–
AI-based omics data analysis solutions are provided to researchers.
cytoreason.com2016Haifa, Israel$100M–
Immune system-based drugs are discovered via biological data analytics.
Premium access

Detailed competitors of Molsoft

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Molsoft

The website of Molsoft (molsoft.com) receives about 18.2K visits a month.

  • Monthly visits
    18.2K

    ▲ 11% vs previous month

Similar websites

Websites whose visitors overlap most with Molsoft. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
chemaxon.com
100%
102.7K#344,948View details
eyesopen.com
95%
25.2K#1,006,842View details
chemcomp.com
88%
23.1K#1,100,676View details
tripos.com
86%
––View details
enamine.net
86%
58.1K#595,309View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for Molsoft

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Similar companies to Molsoft

10 companies that operate in the same segment as Molsoft (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Molsoft

Molsoft was founded in 1994 and raised its 1st funding round 15 years after it was founded.

Molsoft is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Founded in 1994 and based in San Diego, United States, Molsoft operates in the computational chemistry sector. The ICM suite of molecule design tools is provided in six versions, with add-ons available under a freemium model. Contract research services are also offered, including protein modeling, ligand- and structure-based virtual screening, lead optimization, cheminformatics, and custom software development.

Molsoft's top competitors include Insitro, Helix and HotSpot Therapeutics.

Molsoft offers ICM-Pro, ICM-Pro Homology Module, ICM-Pro Virtual Ligand Screening, ICM-Chemist, and MolScreen.

Molsoft has 1 investor. Key investors include HHS.

Molsoft operates through Molsoft L.L.C..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available